白细胞减少症近年来日渐增多,患者虚弱、乏力,并易发生感染,以致影响劳动出勤。恶性肿瘤患者于化疗或放疗过程中也常因发生白细胞减少而影响治疗的进行。这些均为临床迫切需要解决的课题。 目前,治疗白细胞减少症的药物种类比以往为多,但疗效迅速而肯定的药物较少,且这些药物与核酸代谢有密切关系,其毒性虽不大,但选择性不高,疗效有限。我们曾用“人胚”和“升白宁”治疗28例白细胞减少症,发现有一定的疗效,兹将初步体会介绍如下。 Leukopenia in recent years, increasing, patients are weak, weak, and prone to infection, resulting in affecting labor attendance. Malignant cancer patients in the course of chemotherapy or radiotherapy is often affected by the occurrence of leukopenia treatment. These are urgent issues to be solved in clinical practice. Currently, the treatment of leucopenia drugs more than ever before, but the rapid and affirmative efficacy of less drugs, and these drugs are closely related to nucleic acid metabolism, although its toxicity is not large, but the selectivity is not high, limited efficacy. We have used “human embryo” and “Bai Ning” treatment of 28 cases of leukopenia and found that there is a certain effect, it will be the initial experience described below.